Birch triterpenes by Chiesi Farmaceutici for Radiodermatitis: Likelihood of Approval

Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.

How physicians should talk to parents of unvaccinated children who have contracted measles

The ongoing measles outbreak in west Texas and a neighboring county in New Mexico has grown to more than 200 cases, concentrated in unvaccinated children.

March 8, 2025

Psyence Biomedical : Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial Form 6K | Psychedelic Invest

NEW YORK, December 17, 2024 — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today highlighted recent progress that has been made with

December 19, 2024

Plastic Surgery Practice Accused of Posting Fake Reviews Must Pay $5 Million

A Seattle-area plastic surgery provider accused of threatening patients over negative reviews and posting fake positive ones must pay $5 million to the state attorney

July 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.